annual net income:
-$1.64B-$1.08B(-193.20%)Summary
- As of today (April 17, 2025), TEVA annual net profit is -$1.64 billion, with the most recent change of -$1.08 billion (-193.20%) on December 31, 2024.
- During the last 3 years, TEVA annual net income has fallen by -$2.06 billion (-493.05%).
- TEVA annual net income is now -149.20% below its all-time high of $3.33 billion, reached on December 31, 2010.
Performance
TEVA Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$217.00M+$220.00M(+50.34%)Summary
- As of today (April 17, 2025), TEVA quarterly net profit is -$217.00 million, with the most recent change of +$220.00 million (+50.34%) on December 31, 2024.
- Over the past year, TEVA quarterly net income has dropped by -$78.00 million (-56.12%).
- TEVA quarterly net income is now -119.38% below its all-time high of $1.12 billion, reached on March 31, 2018.
Performance
TEVA quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$1.64B-$680.00M(-70.91%)Summary
- As of today (April 17, 2025), TEVA TTM net profit is -$1.64 billion, with the most recent change of -$680.00 million (-70.91%) on December 31, 2024.
- Over the past year, TEVA TTM net income has dropped by -$1.16 billion (-242.17%).
- TEVA TTM net income is now -148.51% below its all-time high of $3.38 billion, reached on March 31, 2011.
Performance
TEVA TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TEVA Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -193.2% | -56.1% | -242.2% |
| 3 y3 years | -493.1% | +6.5% | -55.5% |
| 5 y5 years | -64.1% | -244.7% | +58.9% |
TEVA Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -493.1% | +33.0% | -146.9% | +83.5% | -261.8% | +33.0% |
| 5 y | 5-year | -493.1% | +58.9% | -146.9% | +95.0% | -325.8% | +59.3% |
| alltime | all time | -149.2% | +89.9% | -119.4% | +98.1% | -148.5% | +89.9% |
Teva Pharmaceutical Industries Limited Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$1.64B(+193.2%) | -$217.00M(-50.3%) | -$1.64B(+70.9%) |
| Sep 2024 | - | -$437.00M(-48.3%) | -$959.00M(+111.7%) |
| Jun 2024 | - | -$846.00M(+508.6%) | -$453.00M(-5.4%) |
| Mar 2024 | - | -$139.00M(-130.0%) | -$479.00M(-14.5%) |
| Dec 2023 | -$559.00M(-77.1%) | $463.00M(+571.0%) | -$560.00M(-76.0%) |
| Sep 2023 | - | $69.00M(-107.9%) | -$2.34B(-0.6%) |
| Jun 2023 | - | -$872.00M(+296.4%) | -$2.35B(+37.4%) |
| Mar 2023 | - | -$220.00M(-83.3%) | -$1.71B(-30.1%) |
| Dec 2022 | -$2.45B(-686.6%) | -$1.31B(-2446.4%) | -$2.44B(+89.5%) |
| Sep 2022 | - | $56.00M(-124.1%) | -$1.29B(+22.4%) |
| Jun 2022 | - | -$232.00M(-75.7%) | -$1.05B(+71.4%) |
| Mar 2022 | - | -$955.00M(+500.6%) | -$615.00M(-247.5%) |
| Dec 2021 | $417.00M(-110.5%) | -$159.00M(-154.5%) | $417.00M(-42.6%) |
| Sep 2021 | - | $292.00M(+41.1%) | $726.00M(-118.5%) |
| Jun 2021 | - | $207.00M(+168.8%) | -$3.92B(-1.7%) |
| Mar 2021 | - | $77.00M(-48.7%) | -$3.98B(-0.2%) |
| Dec 2020 | -$3.99B(+299.4%) | $150.00M(-103.4%) | -$3.99B(-1.0%) |
| Sep 2020 | - | -$4.35B(-3206.4%) | -$4.03B(<-9900.0%) |
| Jun 2020 | - | $140.00M(+102.9%) | $4.00M(-100.5%) |
| Mar 2020 | - | $69.00M(-36.7%) | -$825.00M(-17.4%) |
| Dec 2019 | -$999.00M(-53.5%) | $109.00M(-134.7%) | -$999.00M(-75.0%) |
| Sep 2019 | - | -$314.00M(-54.4%) | -$3.99B(+2.7%) |
| Jun 2019 | - | -$689.00M(+556.2%) | -$3.89B(+15.2%) |
| Mar 2019 | - | -$105.00M(-96.4%) | -$3.38B(+57.0%) |
| Dec 2018 | -$2.15B(-86.8%) | -$2.89B(+1287.5%) | -$2.15B(-80.1%) |
| Sep 2018 | - | -$208.00M(+18.2%) | -$10.80B(+8.0%) |
| Jun 2018 | - | -$176.00M(-115.7%) | -$10.00B(-36.7%) |
| Mar 2018 | - | $1.12B(-109.7%) | -$15.79B(-2.9%) |
| Dec 2017 | -$16.27B(-5043.8%) | -$11.54B(-2038.7%) | -$16.27B(+185.2%) |
| Sep 2017 | - | $595.00M(-110.0%) | -$5.70B(-3.1%) |
| Jun 2017 | - | -$5.97B(-1025.6%) | -$5.89B(-1841.4%) |
| Mar 2017 | - | $645.00M(-166.3%) | $338.00M(+2.7%) |
| Dec 2016 | $329.00M(-79.3%) | -$973.00M(-336.2%) | $329.00M(-81.7%) |
| Sep 2016 | - | $412.00M(+62.2%) | $1.80B(+20.7%) |
| Jun 2016 | - | $254.00M(-60.1%) | $1.49B(-16.0%) |
| Mar 2016 | - | $636.00M(+27.2%) | $1.78B(+12.0%) |
| Dec 2015 | $1.59B(-48.0%) | $500.00M(+385.4%) | $1.59B(-10.5%) |
| Sep 2015 | - | $103.00M(-80.9%) | $1.77B(-30.3%) |
| Jun 2015 | - | $539.00M(+20.9%) | $2.55B(-7.6%) |
| Mar 2015 | - | $446.00M(-35.1%) | $2.76B(-9.8%) |
| Dec 2014 | $3.06B(+140.7%) | $687.00M(-21.6%) | $3.06B(+11.2%) |
| Sep 2014 | - | $876.00M(+17.1%) | $2.75B(+6.4%) |
| Jun 2014 | - | $748.00M(+0.5%) | $2.58B(+86.8%) |
| Mar 2014 | - | $744.00M(+95.8%) | $1.38B(+9.0%) |
| Dec 2013 | $1.27B(-35.4%) | $380.00M(-46.6%) | $1.27B(+5.0%) |
| Sep 2013 | - | $711.00M(-257.3%) | $1.21B(+188.5%) |
| Jun 2013 | - | -$452.00M(-171.7%) | $419.00M(-75.8%) |
| Mar 2013 | - | $630.00M(+96.9%) | $1.73B(-11.7%) |
| Dec 2012 | $1.96B(-28.9%) | $320.00M(-505.1%) | $1.96B(-8.7%) |
| Sep 2012 | - | -$79.00M(-109.2%) | $2.15B(-31.6%) |
| Jun 2012 | - | $863.00M(+0.5%) | $3.14B(+10.0%) |
| Mar 2012 | - | $859.00M(+69.8%) | $2.86B(+3.6%) |
| Dec 2011 | $2.76B(-17.2%) | $506.00M(-44.8%) | $2.76B(-8.8%) |
| Sep 2011 | - | $916.00M(+59.0%) | $3.02B(-4.2%) |
| Jun 2011 | - | $576.00M(-24.3%) | $3.16B(-6.5%) |
| Mar 2011 | - | $761.00M(-1.3%) | $3.38B(+1.4%) |
| Dec 2010 | $3.33B(+66.5%) | $771.00M(-26.6%) | $3.33B(+13.3%) |
| Sep 2010 | - | $1.05B(+31.7%) | $2.94B(+15.8%) |
| Jun 2010 | - | $797.00M(+11.8%) | $2.54B(+12.2%) |
| Mar 2010 | - | $713.00M(+88.1%) | $2.26B(+13.1%) |
| Dec 2009 | $2.00B(+215.0%) | $379.00M(-41.6%) | $2.00B(+114.4%) |
| Sep 2009 | - | $649.00M(+24.6%) | $933.00M(+1.3%) |
| Jun 2009 | - | $521.00M(+15.5%) | $921.00M(-1.9%) |
| Mar 2009 | - | $451.00M(-165.6%) | $939.00M(+47.9%) |
| Dec 2008 | $635.00M(-67.5%) | -$688.00M(-208.0%) | $635.00M(-66.5%) |
| Sep 2008 | - | $637.00M(+18.2%) | $1.89B(+6.3%) |
| Jun 2008 | - | $539.00M(+266.7%) | $1.78B(+1.4%) |
| Mar 2008 | - | $147.00M(-74.2%) | $1.76B(-10.0%) |
| Dec 2007 | $1.95B(+257.5%) | $570.00M(+8.6%) | $1.95B(+6.0%) |
| Sep 2007 | - | $525.00M(+1.9%) | $1.84B(-4.2%) |
| Jun 2007 | - | $515.00M(+50.6%) | $1.92B(+1.4%) |
| Mar 2007 | - | $342.00M(-25.6%) | $1.90B(+247.6%) |
| Dec 2006 | $546.00M(-49.1%) | $459.90M(-24.2%) | $545.70M(+39.8%) |
| Sep 2006 | - | $606.40M(+24.2%) | $390.40M(+664.0%) |
| Jun 2006 | - | $488.40M(-148.4%) | $51.10M(-126.1%) |
| Mar 2006 | - | -$1.01B(-431.3%) | -$196.10M(-118.3%) |
| Dec 2005 | $1.07B | $304.60M(+14.0%) | $1.07B(+2.4%) |
| Sep 2005 | - | $267.10M(+10.7%) | $1.05B(+1.5%) |
| Jun 2005 | - | $241.20M(-6.9%) | $1.03B(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $259.10M(-7.1%) | $1.02B(+207.0%) |
| Dec 2004 | $332.00M(-52.0%) | $279.00M(+10.9%) | $332.00M(+38.7%) |
| Sep 2004 | - | $251.50M(+9.6%) | $239.30M(+65.7%) |
| Jun 2004 | - | $229.50M(-153.6%) | $144.40M(+15.2%) |
| Mar 2004 | - | -$428.00M(-329.7%) | $125.30M(-81.9%) |
| Dec 2003 | $691.00M(+68.4%) | $186.30M(+19.0%) | $691.00M(+7.8%) |
| Sep 2003 | - | $156.60M(-25.6%) | $641.20M(+10.4%) |
| Jun 2003 | - | $210.40M(+52.8%) | $580.90M(+25.6%) |
| Mar 2003 | - | $137.70M(+0.9%) | $462.40M(+12.7%) |
| Dec 2002 | $410.30M(+47.5%) | $136.50M(+41.7%) | $410.30M(+16.1%) |
| Sep 2002 | - | $96.30M(+4.8%) | $353.41M(+5.0%) |
| Jun 2002 | - | $91.90M(+7.4%) | $336.51M(+8.9%) |
| Mar 2002 | - | $85.60M(+7.5%) | $309.06M(+11.1%) |
| Dec 2001 | $278.21M(+87.5%) | $79.61M(+0.3%) | $278.21M(+9.7%) |
| Sep 2001 | - | $79.40M(+23.2%) | $253.55M(+14.9%) |
| Jun 2001 | - | $64.45M(+17.7%) | $220.76M(+33.5%) |
| Mar 2001 | - | $54.75M(-0.4%) | $165.30M(+11.4%) |
| Dec 2000 | $148.42M(+27.1%) | $54.95M(+17.9%) | $148.42M(+12.1%) |
| Sep 2000 | - | $46.61M(+418.2%) | $132.44M(+27.1%) |
| Jun 2000 | - | $8.99M(-76.2%) | $104.24M(-17.5%) |
| Mar 2000 | - | $37.86M(-2.9%) | $126.34M(+8.2%) |
| Dec 1999 | $116.78M(+64.9%) | $38.98M(+111.8%) | $116.78M(+43.8%) |
| Sep 1999 | - | $18.40M(-40.8%) | $81.20M(-7.8%) |
| Jun 1999 | - | $31.10M(+9.9%) | $88.10M(+18.9%) |
| Mar 1999 | - | $28.30M(+731.6%) | $74.10M(+4.5%) |
| Dec 1998 | $70.80M(-30.2%) | $3.40M(-86.5%) | $70.90M(+4.6%) |
| Sep 1998 | - | $25.30M(+48.0%) | $67.80M(-13.4%) |
| Jun 1998 | - | $17.10M(-31.9%) | $78.30M(-17.8%) |
| Mar 1998 | - | $25.10M(+8266.7%) | $95.20M(-6.3%) |
| Dec 1997 | $101.50M(+38.3%) | $300.00K(-99.2%) | $101.60M(-22.7%) |
| Sep 1997 | - | $35.80M(+5.3%) | $131.50M(+9.9%) |
| Jun 1997 | - | $34.00M(+7.9%) | $119.60M(+44.8%) |
| Mar 1997 | - | $31.50M(+4.3%) | $82.60M(+12.5%) |
| Dec 1996 | $73.40M(+4.4%) | $30.20M(+26.4%) | $73.40M(+37.2%) |
| Sep 1996 | - | $23.90M(-896.7%) | $53.50M(+4.5%) |
| Jun 1996 | - | -$3.00M(-113.5%) | $51.20M(-30.5%) |
| Mar 1996 | - | $22.30M(+116.5%) | $73.70M(+4.8%) |
| Dec 1995 | $70.30M(+4.0%) | $10.30M(-52.3%) | $70.30M(-6.1%) |
| Sep 1995 | - | $21.60M(+10.8%) | $74.90M(+5.8%) |
| Jun 1995 | - | $19.50M(+3.2%) | $70.80M(+1.9%) |
| Mar 1995 | - | $18.90M(+26.8%) | $69.50M(+2.7%) |
| Dec 1994 | $67.60M(+17.6%) | $14.90M(-14.9%) | $67.70M(-1.9%) |
| Sep 1994 | - | $17.50M(-3.8%) | $69.00M(+5.5%) |
| Jun 1994 | - | $18.20M(+6.4%) | $65.40M(+7.0%) |
| Mar 1994 | - | $17.10M(+5.6%) | $61.10M(+6.3%) |
| Dec 1993 | $57.50M(+81.4%) | $16.20M(+16.5%) | $57.50M(+10.8%) |
| Sep 1993 | - | $13.90M(0.0%) | $51.90M(+16.1%) |
| Jun 1993 | - | $13.90M(+3.0%) | $44.70M(+18.3%) |
| Mar 1993 | - | $13.50M(+27.4%) | $37.80M(+18.1%) |
| Dec 1992 | $31.70M(+33.8%) | $10.60M(+58.2%) | $32.00M(+12.7%) |
| Sep 1992 | - | $6.70M(-4.3%) | $28.40M(+7.6%) |
| Jun 1992 | - | $7.00M(-9.1%) | $26.40M(+0.8%) |
| Mar 1992 | - | $7.70M(+10.0%) | $26.20M(+10.5%) |
| Dec 1991 | $23.70M(+13.9%) | $7.00M(+48.9%) | $23.70M(-9.5%) |
| Sep 1991 | - | $4.70M(-30.9%) | $26.20M(+4.8%) |
| Jun 1991 | - | $6.80M(+30.8%) | $25.00M(+14.2%) |
| Mar 1991 | - | $5.20M(-45.3%) | $21.90M(+3.3%) |
| Dec 1990 | $20.80M(+23.1%) | $9.50M(+171.4%) | $21.20M(+26.9%) |
| Sep 1990 | - | $3.50M(-5.4%) | $16.70M(0.0%) |
| Jun 1990 | - | $3.70M(-17.8%) | $16.70M(+1.2%) |
| Mar 1990 | - | $4.50M(-10.0%) | $16.50M(-2.4%) |
| Dec 1989 | $16.90M(+40.8%) | $5.00M(+42.9%) | $16.90M(+15.8%) |
| Sep 1989 | - | $3.50M(0.0%) | $14.60M(+10.6%) |
| Jun 1989 | - | $3.50M(-28.6%) | $13.20M(-0.8%) |
| Mar 1989 | - | $4.90M(+81.5%) | $13.30M(+10.8%) |
| Dec 1988 | $12.00M(-18.9%) | $2.70M(+28.6%) | $12.00M(+29.0%) |
| Sep 1988 | - | $2.10M(-41.7%) | $9.30M(-7.0%) |
| Jun 1988 | - | $3.60M(0.0%) | $10.00M(+8.7%) |
| Mar 1988 | - | $3.60M(+28.6%) | $9.20M(-29.2%) |
| Sep 1987 | - | $2.80M(0.0%) | $13.00M(-6.5%) |
| Jun 1987 | - | $2.80M(-24.3%) | $13.90M(-6.1%) |
| Mar 1987 | $14.80M(+94.7%) | $3.70M(0.0%) | $14.80M(+13.8%) |
| Dec 1986 | - | $3.70M(0.0%) | $13.00M(+16.1%) |
| Sep 1986 | - | $3.70M(0.0%) | $11.20M(+19.1%) |
| Jun 1986 | - | $3.70M(+94.7%) | $9.40M(+23.7%) |
| Mar 1986 | $7.60M | $1.90M(0.0%) | $7.60M(+33.3%) |
| Dec 1985 | - | $1.90M(0.0%) | $5.70M(+50.0%) |
| Sep 1985 | - | $1.90M(0.0%) | $3.80M(+100.0%) |
| Jun 1985 | - | $1.90M | $1.90M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual net profit?
- What is the all time high annual net income for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual net income year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly net profit?
- What is the all time high quarterly net income for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly net income year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM net profit?
- What is the all time high TTM net income for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM net income year-on-year change?
What is Teva Pharmaceutical Industries Limited annual net profit?
The current annual net income of TEVA is -$1.64B
What is the all time high annual net income for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual net profit is $3.33B
What is Teva Pharmaceutical Industries Limited annual net income year-on-year change?
Over the past year, TEVA annual net profit has changed by -$1.08B (-193.20%)
What is Teva Pharmaceutical Industries Limited quarterly net profit?
The current quarterly net income of TEVA is -$217.00M
What is the all time high quarterly net income for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly net profit is $1.12B
What is Teva Pharmaceutical Industries Limited quarterly net income year-on-year change?
Over the past year, TEVA quarterly net profit has changed by -$78.00M (-56.12%)
What is Teva Pharmaceutical Industries Limited TTM net profit?
The current TTM net income of TEVA is -$1.64B
What is the all time high TTM net income for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM net profit is $3.38B
What is Teva Pharmaceutical Industries Limited TTM net income year-on-year change?
Over the past year, TEVA TTM net profit has changed by -$1.16B (-242.17%)